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etter to the Editor
range  sputum  in a  kidney  transplant  patient  with
egionella micdadei  pneumoniasputo  anaranjado  en  el  contexto  de  neumonía  por  Legionella
icdadei  en  un  paciente  trasplantado  renal
Table 1 – Patient’s analytical parameters on admission.
Leucocytes (l) 5200
Haemoglobin (g/dl) 10.9
Platelets (l) 103 × 109
Creatinine (mg/dl) 3.89
Urea (mg/dl) 176
C-reactive protein (mg/l) 378.2
pH 7.38
PaO2 (kPa)/FiO2 50% 10.21
was re-introduced for an additional 10 day period. The patientear Sir,
e  present the case of a 54-year-old male with a history
f IgA nephropathy that has progressed to stage 5 chronic
idney disease, for which he received a cadveric kidney trans-
lant in 2011. His immunosuppression treatment included:
acrolimus, mycophenolate mofetil (MMF)  and prednisone,
nd he had a baseline creatinine level of 2.11 mg/dl. Two
onths prior to admission, he was started on treatment
ith corticosteroids at a dose of 1 mg/kg, subsequently in
apering regimen, due to a recent diagnosis of borderline
ejection.
The patient was admitted to our hospital with respiratory
ailure in the context of bilobar pneumonia. Table 1 shows
ome of the patient’s analytical parameters on admission.
The chest X-ray showed inﬁltrates in the right and left lower
obes. It was initially treated empirically with ceftriaxone and
evoﬂoxacin. Due to the poor clinical progress, the ceftriaxone
as changed to meropenem, and the levoﬂoxacin was with-
rawn as the urinary antigen test for Legionella pneumophila (L.
neumophila) was negative. He was then also started on co-
rimoxazole. The serial blood and sputum cultures obtained
n admission were negative, as were the selective cultures for
egionella, Nocardia and fungi. The test for inﬂuenza A and B
n nasopharyngeal aspirate was negative. Acid-fast bacillus
taining and ﬂuid and solid cultures also resulted negative.
uantitative PCR for the detection of cytomegalovirus in blood
nly revealed 93 CMV  copies/ml.
Despite broad-spectrum antibiotic treatment, the patient
emained febrile and had high oxygen requirements at day ﬁve
 Please cite this article as: Soler-Majoral J, Sánchez-Escuredo A, P
S,  et al. Esputo anaranjado en el contexto de neumonía por Legione
ttp://dx.doi.org/10.1016/j.nefro.2016.03.002PaCO2 (kPa) 2.58
HCO3 (mmol/l) 12
after admission; thus, the treatment of immunosuppression
with tacrolimus and MMF  was discontinued. A bronchoscopy
was performed with non-invasive ventilation, bronchoalveo-
lar lavage (BAL) and tracheal aspirate were collected for
cultures of conventional bacteria, Pneumocystis jirovecii, acid-
fast bacilli and selective cultures for Legionella, Nocardia, fungi
and mycobacteria.
On day 10, the patient’s general condition deteriorated,
with high fever (39.3 ◦C), coinciding with expectoration of a
large amount of orange colour sputum (Fig. 1). We  decided to
add vancomycin and clindamycin to the treatment. Finally, on
day 12 in hospital, colonies of Legionella micdadei (L. micdadei)
were isolated in the BAL and tracheal aspirate cultures. All
antibiotics were discontinued and treatment with levoﬂoxacinrat Aymerich C, Sanchis Vidal E, Marín-Tàpia A, Prats Bardají
lla micdadei en un paciente trasplantado renal. Nefrologia. 2016.
continued to have intermittent episodes of expectoration of
large amounts of orange like sputum for a few more  days but,
ultimately, he made good clinical progress. It was possible
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c,d c,dFig. 1 – Orange sputum.
to re-introduce the immunosuppressant treatment and his
kidney function returned to previous levels.
Discussion
One of the most common causes of undiagnosed community-
acquired pneumonia is infection by Legionella spp.; L.
pneumophila is responsible for around 85% of the cases of
Legionella infection, with L. micdadei the second most common
cause, responsible for 60% of infections by Legionella species
other than L. pneumophila.1
Outbreaks of community-acquired pneumonia due to
Legionella species other than L. pneumophila are uncommon,1,2
although the fact that culture and isolation of Legionella is so
difﬁcult means that the diagnosis is omitted in some cases.
Infection by L. micdadei is more  likely than L. pneumophila to be
found in immunocompromised patients, and lower mortality
rates have been reported.3
No differences in clinical presentation have been described
between L. pneumophila and L. micdadei pneumonia. The gold
standard test for diagnosis is the culture of respiratory sec-
retions using Buffered Charcoal Yeast Extract (BCYE) agar.
However, due to its viability and speed, detection of L. pneu-
mophila serogroup 1 antigen in urine has become one of the x x(x  x):xxx–xxx
methods most commonly used. The tests used, are able to
detect the urinary antigen for all serogroups of L. pneumophila
and some for other species, but the highest sensitivity is
achieved with the detection of L. pneumophila serogroup 1
antigen.4
It has been reported that orange-like sputum in a patient
with pneumonia is suggestive of infection by L. pneumophila.
Fujita et al.5 put forward that the orange-coloured sputum is
caused by factors released by L. pneumophila that interact with
the tyrosine in the ﬂuids in the epithelial lining.
In our case, we were dealing with an isolated case of
community-acquired L. micdadei pneumonia in an immuno-
suppressed patient. Although the infection was originally
being empirically covered with a quinolone, the negative urine
test for Legionella led to us withdraw that treatment. However,
that test has very low sensitivity for the diagnosis of Legionella
infections other than L. pneumophila. For that reason, in the
particular case of immunocompromised patients with pneu-
monia without alternative aetiology, we suggest that empirical
treatment against Legionella spp. should not be discontinued
until infection by species other than L. pneumophilia has been
ruled out, or until the patient shows good progress with the
conventional treatment.
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